APA
Aguzzi M. S., Faraone D., D'Arcangelo D., De Marchis F., Toietta G., Ribatti D., Parazzoli A., Colombo P., Capogrossi M. C. & Facchiano A. (20110511). The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.
Chicago
Aguzzi Maria S, Faraone Debora, D'Arcangelo Daniela, De Marchis Francesco, Toietta Gabriele, Ribatti Domenico, Parazzoli Alberto, Colombo Paolo, Capogrossi Maurizio C and Facchiano Antonio. 20110511. The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.
Harvard
Aguzzi M. S., Faraone D., D'Arcangelo D., De Marchis F., Toietta G., Ribatti D., Parazzoli A., Colombo P., Capogrossi M. C. and Facchiano A. (20110511). The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy.
MLA
Aguzzi Maria S, Faraone Debora, D'Arcangelo Daniela, De Marchis Francesco, Toietta Gabriele, Ribatti Domenico, Parazzoli Alberto, Colombo Paolo, Capogrossi Maurizio C and Facchiano Antonio. The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo. : Molecular therapy : the journal of the American Society of Gene Therapy. 20110511.